Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 32


miRò: a miRNA knowledge base.

Laganà A, Forte S, Giudice A, Arena MR, Puglisi PL, Giugno R, Pulvirenti A, Shasha D, Ferro A.

Database (Oxford). 2009;2009:bap008. Epub 2009 Aug 4.


miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7.

Sun Y, Bai Y, Zhang F, Wang Y, Guo Y, Guo L.

Biochem Biophys Res Commun. 2010 Jan 15;391(3):1483-9. doi: 10.1016/j.bbrc.2009.12.098. Epub 2009 Dec 24.


Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue.

Corbetta S, Vaira V, Guarnieri V, Scillitani A, Eller-Vainicher C, Ferrero S, Vicentini L, Chiodini I, Bisceglia M, Beck-Peccoz P, Bosari S, Spada A.

Endocr Relat Cancer. 2010 Feb 18;17(1):135-46. doi: 10.1677/ERC-09-0134. Print 2010 Mar.


MicroRNAs in cancer: small molecules with a huge impact.

Iorio MV, Croce CM.

J Clin Oncol. 2009 Dec 1;27(34):5848-56. doi: 10.1200/JCO.2009.24.0317. Epub 2009 Nov 2. Review.


MicroRNA expression, survival, and response to interferon in liver cancer.

Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S, Ambs S, Chen Y, Meltzer PS, Croce CM, Qin LX, Man K, Lo CM, Lee J, Ng IO, Fan J, Tang ZY, Sun HC, Wang XW.

N Engl J Med. 2009 Oct 8;361(15):1437-47. doi: 10.1056/NEJMoa0901282.


MicroRNA profiling and head and neck cancer.

Liu X, Chen Z, Yu J, Xia J, Zhou X.

Comp Funct Genomics. 2009:837514. doi: 10.1155/2009/837514. Epub 2009 Jun 1.


Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma.

Lu Y, Ryan SL, Elliott DJ, Bignell GR, Futreal PA, Ellison DW, Bailey S, Clifford SC.

PLoS One. 2009 Jul 7;4(7):e6159. doi: 10.1371/journal.pone.0006159.


CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.

Guled M, Lahti L, Lindholm PM, Salmenkivi K, Bagwan I, Nicholson AG, Knuutila S.

Genes Chromosomes Cancer. 2009 Jul;48(7):615-23. doi: 10.1002/gcc.20669.


MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo.

Liu B, Peng XC, Zheng XL, Wang J, Qin YW.

Lung Cancer. 2009 Nov;66(2):169-75. doi: 10.1016/j.lungcan.2009.01.010. Epub 2009 Feb 14.


Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease.

Jardin F, Callanan M, Penther D, Ruminy P, Troussard X, Kerckaert JP, Figeac M, Parmentier F, Rainville V, Vaida I, Bertrand P, Duval AB, Picquenot JM, Chaperot L, Marolleau JP, Plumas J, Tilly H, Bastard C.

Leukemia. 2009 Apr;23(4):698-707. doi: 10.1038/leu.2008.359. Epub 2009 Jan 22. Erratum in: Leukemia. 2009 Apr;23(4):825-6.


Defining a molecular phenotype for benign and malignant parathyroid tumors.

Fernandez-Ranvier GG, Khanafshar E, Tacha D, Wong M, Kebebew E, Duh QY, Clark OH.

Cancer. 2009 Jan 15;115(2):334-44. doi: 10.1002/cncr.24037.


Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma.

Howell VM, Gill A, Clarkson A, Nelson AE, Dunne R, Delbridge LW, Robinson BG, Teh BT, Gimm O, Marsh DJ.

J Clin Endocrinol Metab. 2009 Feb;94(2):434-41. doi: 10.1210/jc.2008-1740. Epub 2008 Nov 18.


Megakaryocytic expression of miRNA 10a, 17-5p, 20a and 126 in Philadelphia chromosome-negative myeloproliferative neoplasm.

Hussein K, Dralle W, Theophile K, Kreipe H, Bock O.

Ann Hematol. 2009 Apr;88(4):325-32. doi: 10.1007/s00277-008-0602-9. Epub 2008 Sep 5.


The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers.

Guo C, Sah JF, Beard L, Willson JK, Markowitz SD, Guda K.

Genes Chromosomes Cancer. 2008 Nov;47(11):939-46. doi: 10.1002/gcc.20596.


miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia.

Zanette DL, Rivadavia F, Molfetta GA, Barbuzano FG, Proto-Siqueira R, Silva-Jr WA, Falcão RP, Zago MA.

Braz J Med Biol Res. 2007 Nov;40(11):1435-40.


Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?

Cetani F, Ambrogini E, Viacava P, Pardi E, Fanelli G, Naccarato AG, Borsari S, Lemmi M, Berti P, Miccoli P, Pinchera A, Marcocci C.

Eur J Endocrinol. 2007 May;156(5):547-54.


Trends in the incidence and treatment of parathyroid cancer in the United States.

Lee PK, Jarosek SL, Virnig BA, Evasovich M, Tuttle TM.

Cancer. 2007 May 1;109(9):1736-41.


Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype.

Haven CJ, Howell VM, Eilers PH, Dunne R, Takahashi M, van Puijenbroek M, Furge K, Kievit J, Tan MH, Fleuren GJ, Robinson BG, Delbridge LW, Philips J, Nelson AE, Krause U, Dralle H, Hoang-Vu C, Gimm O, Morreau H, Marsh DJ, Teh BT.

Cancer Res. 2004 Oct 15;64(20):7405-11.


MicroRNAs: genomics, biogenesis, mechanism, and function.

Bartel DP.

Cell. 2004 Jan 23;116(2):281-97. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk